Supplementary Figure 5 from ESR1 Mutations and Overall Survival on Fulvestrant versus Exemestane in Advanced Hormone Receptor–Positive Breast Cancer: A Combined Analysis of the Phase III SoFEA and EFECT Trials

Authors :: Stephen K. Chia
Stephen R.D. Johnston
Mitch Dowsett
Judith M. Bliss
Gaia Schiavon
Martine Piccart
William Gradishar
John F.R. Robertson
Aman U. Budzar
Isaac Garcia-Murillas
Matthew Beaney
Charlotte Fribbens
Lucy Kilburn
Claire Swift
Nicholas C. Turner
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Figure 5. Progression free survival by ESR1 mutation detected in ctDNA

Full Text Access

Tools